Quality of Life in Elderly Patients With Metastatic Colorectal Cancer Receiving First-line Therapy Based on Simplified Geriatric Parameters

• Status: Recruiting
• Trial end date: 2024-09-30

Summary

A national, multicenter, open-label, randomized phase III study. The trial aim is to determine the best therapeutic strategies according with the HRQoL.

• Phase: Phase 3

Details

• Lead Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
• Treatments: Bevacizumab; Capecitabine